What we do
We create and commercialize transformative solutions to the health, wellness and sustainable development
challenges of our time using our novel Convergence Innovation® platform. We collaborate with leading
stakeholders worldwide to enable rapid commercialization, and we embed ESG social responsibility as core
elements in all of our initiatives

Healthcare
Addressing global challenges in human health and wellness

Nutrition Security
Sustainable food production to improve global nutrition security

Sustainability
Pioneering solutions to assure long-term environmental health
Convergence Innovation™ Uniquely integrated Platform
Huminn is an innovations company at the forefront of science and technology. Working with leading, interdisciplinary scientists, Huminn deploys cutting edge precision molecular biology tools with proprietary and novel statistical prediction algorithms to create and commercialize visionary integrated solutions to critical global challenges in health, wellness and sustainable development
Agriculture
We create breakthrough, sustainable agriculture and food supply chains
Commercial Partnerships
Our unique convergence model drives rapid commercialization and monetization of codeveloped, protectable inventions
Informatics
We utilize next-generation tools for interoperable data capture, curation, quality control, statistical classification and predictive modeling
Biosciences
We are committed to improving public health by transforming disease management globally with revolutionary
diagnostic and planned treatment
products
Huminn connects dots
Others compartmentalize. Huminn connects dots. Others see problems. Huminn marries new tech, new thinking, and a new cast of collaborators to create sustainable solutions that have significant positive economic, environmental and cultural impact
Global Needs
Identify and articulate global pain points
Exploration
Ideate game-changing solutions
Solution Development
Develop solutions with strategic partners on our interdisciplinary innovation platform
Solution Commercialization
Deploy solutions at scale to strategic partners and other target consumers
Global Market
Positively transform everyday life around the world

Huminn Platform
A unique collaborative platform of leading research and technological breakthroughs

Breakthrough, Standalone Liquid Biopsy Urine Test for Prostate Cancer

We bring humanity and sustainability to the production of the world’s leading protein source

Developing sustainable plant-based technology solutions to address the unmet needs of health, food production and the environment

Reduce Cow-Emission

Representative Technology Collaborations
Huminn harnesses, develops and commercializes the most compelling technical capabilities it conceives or identifies by working closely with strategic collaboration partners, leading researchers and centers of excellence in innovation. By aligning common core interests, Huminn co-develops protectable inventions and exclusive rights to applied research with revolutionary technical potential

Agricultural Research Organization, Volcani Center

Ben-Gurion University of the Negev

NIBN - The National Institue for Biotechnology in the Negev Ltd.

Institute of Animal Science, Agricultural Research Organization

Agricultural Research Organization, Volcani Center

The Chaim Sheba Medical Center

Israel Oceanographic and Limnological Research
Leadership Team

Sam Salman
Chairman & CEO of Huminn

Eli Mor
President, Head of International

Martin Tenniswood, Ph.D.
Huminn Group Chief Scientific Officer

Gregory DiRienzo, Ph.D.
Head of Huminn Data Science

Tal Kimmel
Global Head, Corporate Development

JoEllen Welsh, Ph.D.
Head of Bioscience

Ram Salman
Chief Technology Officer & Systems Architect

Yaarit Wainberg, Ph.D., MBA
Chief Executive Officer – Huminn Poultry

Keren Nir
VP Marcom and PR

Eyal Emmanuel
Chief Scientific Officer – Israel Operations

Avital Barlev
Chief Operating Officer

Eli Avraham
Chief Finance Officer - Israel Operations

Amnon Katz, PhD.
Chief Operations Officer – Bio Sciences Pharma

Robert F. Flippin
Vice Chairman

Eytan Meisels, Ph.D.
VP Regulatory Affairs

Charles H. Columbus
Advisor
Advisory Team

Sebastiano Cossia Castiglioni
Senior Strategic Advisor

Joel H. Levitin
Advisor

Henry Weinstein
Senior Strategic Advisor

Dr. Allen Barnett
Advisor

Yuval Eshdat, Ph.D.
Chairman of Scientific Advisory and Policy Board, Israel Operations

Alejandro Weinstein
Senior Strategic Advisor

Dr. Deepak A. Kapoor
Senior Strategic Advisor